Cargando…

The Significance of PAX8-PPARγ Expression in Thyroid Cancer and the Application of a PAX8-PPARγ-Targeted Ultrasound Contrast Agent in the Early Diagnosis of Thyroid Cancer

OBJECTIVE: To investigate the significance of PAX8-PPARγ expression in thyroid cancer and the application of a PAX8-PPARγ-targeted ultrasound contrast agent in the early diagnosis of thyroid cancer. METHODS: In this study, the expression of PAX8-PPARγ in thyroid cancer tissues, paracancer groups, an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Tianbing, Zhu, Wenbo, Kong, Min, Yang, Xiaochan, Wang, Cheng, Wang, Min, Wang, Zhaoyin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9246593/ https://www.ncbi.nlm.nih.gov/pubmed/35833067 http://dx.doi.org/10.1155/2022/3265342

Ejemplares similares

The Role of the PAX8/PPARγ Fusion Oncogene in Thyroid Cancer
por: Placzkowski, Kimberly A., et al.
Publicado: (2008)

Underexpression of peroxisome proliferator-activated receptor (PPAR)γ in PAX8/PPARγ-negative thyroid tumours
por: Marques, A R, et al.
Publicado: (2004)

Rapid methods to create a positive control and identify the PAX8/PPARγ rearrangement in FNA thyroid samples by molecular biology
por: Vuttariello, Emilia, et al.
Publicado: (2018)

PPARγ Promotes Growth and Invasion of Thyroid Cancer Cells
por: Wood, William M., et al.
Publicado: (2011)

Expression of PAX8 Target Genes in Papillary Thyroid Carcinoma
por: Rosignolo, Francesca, et al.
Publicado: (2016)

Recovery of NIS expression in thyroid cancer cells by overexpression of Pax8 gene
por: Presta, Ivan, et al.
Publicado: (2005)

PPARγ Targets-Derived Diagnostic and Prognostic Index for Papillary Thyroid Cancer
por: Kim, Jaehyung, et al.
Publicado: (2021)

UnPAXing the Divergent Roles of PAX2 and PAX8 in High-Grade Serous Ovarian Cancer
por: Hardy, Laura R., et al.
Publicado: (2018)

Pax8 controls thyroid follicular polarity through cadherin-16
por: Koumarianou, Petrina, et al.
Publicado: (2017)

PPARγ and Apoptosis in Cancer
por: Elrod, Heath A., et al.
Publicado: (2008)

Neuropilin-2 Is a Newly Identified Target of PAX8 in Thyroid Cells
por: Lucci, Valeria, et al.
Publicado: (2015)

The role and function of PPARγ in bladder cancer
por: Peng, Tianchen, et al.
Publicado: (2020)

PPARγ and MEK Interactions in Cancer
por: Burgermeister, Elke, et al.
Publicado: (2008)

PPARγ and Proline Oxidase in Cancer
por: Phang, James M., et al.
Publicado: (2008)

Significance analysis of PAX8 expression in endometrial carcinoma
por: Hu, Shan, et al.
Publicado: (2022)

PPARγ in Neuroblastoma
por: Peri, Alessandro, et al.
Publicado: (2008)

Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases
por: Kulkarni, Ajit A., et al.
Publicado: (2012)

The PAX8 cistrome in epithelial ovarian cancer
por: Adler, Emily K., et al.
Publicado: (2017)

An Epistatic Interaction between the PAX8 and STK17B Genes in Papillary Thyroid Cancer Susceptibility
por: Landa, Iñigo, et al.
Publicado: (2013)

Genome-wide analysis of Pax8 binding provides new insights into thyroid functions
por: Ruiz-Llorente, Sergio, et al.
Publicado: (2012)

Expression of Pax8 is decreased and bortezomib does not increase the iodine uptake in thyroid carcinoma cells
por: Wang, Huan-jun, et al.
Publicado: (2015)

Scaffold-Based Pan-Agonist Design for the PPARα, PPARβ and PPARγ Receptors
por: Zhang, Li-Song, et al.
Publicado: (2012)

PPAR-γ Modulators as Current and Potential Cancer Treatments
por: Chi, Tiange, et al.
Publicado: (2021)

Expression of peroxisome proliferator-activated receptor (PPAR)γ in gastric cancer and inhibitory effects of PPARγ agonists
por: Sato, H, et al.
Publicado: (2000)

To Live or to Die: Prosurvival Activity of PPARγ in Cancers
por: Wang, Y. Lynn, et al.
Publicado: (2008)

The PPARα and PPARγ Epigenetic Landscape in Cancer and Immune and Metabolic Disorders
por: Porcuna, Jesús, et al.
Publicado: (2021)

Pax2 and Pax8 cooperate in mouse inner ear morphogenesis and innervation
por: Bouchard, Maxime, et al.
Publicado: (2010)

A Role for the PPARγ in Cancer Therapy
por: Campbell, Moray J., et al.
Publicado: (2008)

Clinical Use of PPARγ Ligands in Cancer
por: Hatton, Jennifer L., et al.
Publicado: (2008)

PPARγ, PTEN, and the Fight against Cancer
por: Teresi, Rosemary E., et al.
Publicado: (2008)

PPARγ, neuroinflammation, and disease
por: Mrak, Robert E, et al.
Publicado: (2004)

Nutraceuticals as Ligands of PPARγ
por: Penumetcha, Meera, et al.
Publicado: (2012)

PPARγ and Cognitive Performance
por: d’Angelo, Michele, et al.
Publicado: (2019)

Regulation of Lymphocyte Function by PPARγ: Relevance to Thyroid Eye Disease-Related Inflammation
por: Lehmann, G. M., et al.
Publicado: (2008)

Correction: An Epistatic Interaction between the PAX8 and STK17B Genes in Papillary Thyroid Cancer Susceptibility
por: Landa, Iñigo, et al.
Publicado: (2013)

Phosphorylation of PPARγ Affects the Collective Motions of the PPARγ-RXRα-DNA Complex
por: Lemkul, Justin A., et al.
Publicado: (2015)

Pax8 modulates the expression of Wnt4 that is necessary for the maintenance of the epithelial phenotype of thyroid cells
por: Filippone, Maria Grazia, et al.
Publicado: (2014)

PPARγ and PPARδ as Modulators of Neoplasia and Cell Fate
por: Glazer, Robert I., et al.
Publicado: (2008)

PAX2, PAX8, and PR are correlated with ovarian seromucinous borderline tumor with endometriosis
por: Yun, Bo Seong, et al.
Publicado: (2022)

Synergistic Antiproliferative Effects of Combined γ-Tocotrienol and PPARγ Antagonist Treatment Are Mediated through PPARγ-Independent Mechanisms in Breast Cancer Cells
por: Malaviya, Abhita, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_b6amrscnt3r6474kh0dkcc97hq